About chi9iua
This author has not written his bio yet.
But we are proud to say that chi9iua contributed 41 entries already.
Entries by chi9iua
Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development
/in Corporate News, News/by chi9iuaChime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development Accelerate Polpharma Biologics biosimilar program from IND to commercial manufacturing Includes a commitment to producing for US FDA BLA submission Expand global market presence through launch in EU and other regions April 16, 2025, Gdańsk, Poland and Shanghai, China – Chime Biologics, a leading global […]
Chime Biologics and Great Bay Bio deepen strategic cooperation, using AI to accelerate the development of biopharmaceuticals
/in Corporate News, News, NewsRoom/by chi9iuaChime Biologics and Great Bay Bio deepen strategic cooperation, using AI to accelerate the development of biopharmaceuticals Not availible.
Chime Biologics Supports Mabgeek to Advance MG-K10 into Phase III Trials and Enter the U.S. Market
/in Corporate News, News, NewsRoom/by chi9iuaChime Biologics Supports Mabgeek to Advance MG-K10 into Phase III Trials and Enter the U.S. Market February 21, 2025, Shanghai – Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, today announced its continued collaboration with Mabgeek in advancing MG-K10, a potential Best-in-Class therapy, a novel IL-4Rα-targeting antibody drug for atopic […]
chime biologics and mabgeek celebrate ppq success
/in Corporate News, News, NewsRoom/by chi9iuachime biologics and mabgeek celebrate ppq success Not available.
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization
/in Corporate News, News, NewsRoom/by chi9iuaChime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization -Process Performance Qualification (PPQ) validates robust manufacturing standards and is crucial for regulatory compliance -Marks a key step forward for the world’s first once-monthly IL-4Rα-targeting antibody therapeutic for Th2-driven diseases, with a strategic […]